Breaking News

Charles River Invests in High-Throughput Screening Infrastructure

Signs collaboration agreement with AstraZeneca

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories has signed a new agreement which grants Charles River commercial access to AstraZeneca’s high-throughput screening (HTS) and compound management infrastructure. Through the agreement, Charles River will perform HTS programs for its clients utilizing AstraZeneca’s state-of-the-art HTS facility. “Providing our clients access to AstraZeneca’s HTS technology enhances our existing capabilities by broadening our assay platforms and increasing our a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters